PTC Therapeutics | PTCT - Stock


PTC Therapeutics reported $91.35M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Amgen USD 6.22B 34M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Cytokinetics USD 380K 226K Jun/2026
Daiichi Sankyo JPY 692.38B 83.83B Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Incyte USD 112.54M 3.08M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Novartis USD 6.22B 66M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
TG Therapeutics USD 147.97M 18.94M Jun/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026